0001127602-22-001454.txt : 20220113 0001127602-22-001454.hdr.sgml : 20220113 20220113163814 ACCESSION NUMBER: 0001127602-22-001454 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211214 FILED AS OF DATE: 20220113 DATE AS OF CHANGE: 20220113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gayer Charles K CENTRAL INDEX KEY: 0001800110 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 22529436 MAIL ADDRESS: STREET 1: 4505 EMPEROR BLVD. STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4/A 1 form4a.xml PRIMARY DOCUMENT X0306 4/A 2021-12-14 2021-12-16 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001800110 Gayer Charles K 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 Chief Commercial Officer Common Stock 2021-12-14 4 A 0 80000 0 A 216556 D The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date. /s/ Alane P. Barnes, by power of attorney 2022-01-13